Allecra’s EXBLIFEP approval to treat cUTIs provides valuable new weapon to tackle ESBL mediated AMR:… EP News Bureau Mar 1, 2024 In addition to the FDA approval, EXBLIFEP has also been submitted for marketing approval in the EU and received a positive opinion…
Study finds rise in antibiotic misuse in India during COVID first wave Press Trust of India Jul 5, 2021 The researchers estimated that COVID-19 likely contributed to 216.4 million excess doses of antibiotics and 38 million more doses…
